Pitavastatin Calcium Patent Expiration
Pitavastatin Calcium is Used for improving lipid profiles in patients with hyperlipidemia or mixed dyslipidemia. It was first introduced by Kowa Co Ltd
Pitavastatin Calcium Patents
Given below is the list of patents protecting Pitavastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Livalo | US5753675 | Quinoline analogs of mevalonolactone and derivatives thereof |
May 19, 2015
(Expired) | Kowa Co |
| Livalo | US5854259 | Quinoline type mevalonolactones |
Dec 29, 2015
(Expired) | Kowa Co |
| Livalo | US5856336 | Quinoline type mevalonolactones |
Jan 01, 2021
(Expired) | Kowa Co |
| Livalo |
US5856336 (Pediatric) | Quinoline type mevalonolactones |
Jun 25, 2021
(Expired) | Kowa Co |
| Livalo | US6465477 | Stable pharmaceutical composition |
Dec 20, 2016
(Expired) | Kowa Co |
| Livalo | US7022713 | Hyperlipemia therapeutic agent |
Feb 19, 2024
(Expired) | Kowa Co |
| Livalo |
US7022713 (Pediatric) | Hyperlipemia therapeutic agent | Aug 19, 2024 | Kowa Co |
| Livalo | US8557993 | Crystalline forms of pitavastatin calcium |
Feb 02, 2024
(Expired) | Kowa Co |
| Livalo |
US8557993 (Pediatric) | Crystalline forms of pitavastatin calcium | Aug 02, 2024 | Kowa Co |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Pitavastatin Calcium Generics
Several generic applications have been filed for Pitavastatin Calcium. The first generic version for Pitavastatin Calcium was by Aurobindo Pharma Ltd and was approved on Dec 20, 2016. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Apr 30, 2024.
Given below is the list of companies who have filed for Pitavastatin Calcium generic.
1. ORIENT PHARMA CO LTD
Orient Pharma Co Ltd has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Orient Pharma Co Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Apr 4, 2019 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Apr 4, 2019 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Apr 4, 2019 |
3. SAWAI USA
Sawai Usa Inc has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Sawai Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 3, 2017 |
4. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2023 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2023 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2023 |
5. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2024 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2024 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2024 |
6. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 22, 2023 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 22, 2023 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 22, 2023 |
7. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Pitavastatin Calcium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2016 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2016 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2016 |